ArticleOncology reviews2026
Evaluating the role of BMI in survival and complications in older esophageal squamous cell carcinoma following esophagectomy.
Article in Oncology reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic value of tertiary lymphoid structures in locally advanced esophageal squamous cell carcinoma treated with neoadjuvant chemoimmunotherapy: a retrospective study.Journal of cardiothoracic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To evaluate the impact of Body Mass Index (BMI) on survival and postoperative complications in older patients with esophageal squamous cell carcinoma (ESCC) following esophagectomy, we designed this study. Materials and methods: We retrospectively analyzed 469 patients aged ≥70 years with thoracic ESCC who underwent esophagectomy at Sichuan Cancer Hospital (May 2016-August 2021). Patients were grouped by WHO BMI categories: underweight (<18.5 kg/m Results: Median follow-up was 47.5 months; R0 resection was achieved in 96.4%. BMI distribution: 7.3% low, 76.8% normal, 16.0% high. Median OS was 44.9 months overall, with no significant OS or DFS differences among BMI groups. RCS demonstrated a significant U-shaped association between continuous BMI and survival: protective ranges were approximately 21.9-27.0 kg/m Conclusion: In elderly ESCC patients after esophagectomy, BMI does not independently influence OS or DFS, though low BMI is associated with specific serious complications. Perioperative optimization-particularly nutritional support for underweight patients-remains essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.